Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001015182 | SCV001175991 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-07-02 | criteria provided, single submitter | clinical testing | The p.I774F variant (also known as c.2320A>T), located in coding exon 14 of the MSH2 gene, results from an A to T substitution at nucleotide position 2320. The isoleucine at codon 774 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001860785 | SCV002193596 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-06-26 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003461347 | SCV004196244 | uncertain significance | Lynch syndrome 1 | 2023-09-17 | criteria provided, single submitter | clinical testing |